HIV, Metabolic Syndrome X, Inflammation, Oxidative Stress, and Coronary Heart Disease Risk : Role of Protease Inhibitor Exposure

2004 ◽  
Vol 4 (3) ◽  
pp. 303-316 ◽  
Author(s):  
Barry E. Hurwitz ◽  
Nancy G. Klimas ◽  
Maria M. Llabre ◽  
Kevin J. Maher ◽  
Jay S. Skyler ◽  
...  
2020 ◽  
Vol 45 (7) ◽  
pp. 801-804
Author(s):  
Vladimir Vuksan ◽  
John L. Sievenpiper ◽  
Elena Jovanovski ◽  
Alexandra L. Jenkins ◽  
Allison Komishon ◽  
...  

We applied the Framingham risk equation in healthy, metabolic syndrome, and diabetes populations, following treatment with viscous fibre from konjac-based blend (KBB). KBB yielded reduction in estimated risk score by 16% (1.04 ± 0.03 vs. 0.87 ± 0.04, p < 0.01) in type 2 diabetes, 24% (1.08 ± 0.01 vs. 0.82 ± 0.02, p < 0.01) in metabolic syndrome, and 25% (1.09 ± 0.05 vs. 0.82 ± 0.06, p < 0.01) in healthy individuals. Drivers for decreased risk were improvements in blood cholesterol and systolic blood pressure. The composite coronary heart disease risk across populations was reduced 22% (p < 0.01). Novelty Viscous fibre from konjac-xanthan reduced 10-year relative coronary heart disease using Framingham Risk Score across the glycemic status spectrum.


2016 ◽  
Vol 119 (3) ◽  
pp. 491-499 ◽  
Author(s):  
Maria Carolina Borges ◽  
Debbie A. Lawlor ◽  
Cesar de Oliveira ◽  
Jon White ◽  
Bernardo Lessa Horta ◽  
...  

2001 ◽  
Vol 87 (7) ◽  
pp. 827-831 ◽  
Author(s):  
Gerald Reaven ◽  
Karen Segal ◽  
Jonathan Hauptman ◽  
Mark Boldrin ◽  
Charles Lucas

Sign in / Sign up

Export Citation Format

Share Document